Search research articles
Contact Us
Filters
Showing results (21-30 of 164) with videos related to
Page
of 17
Sort By:
Journal of Neuro-Oncology
|
June 5, 2010
Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report
Lisa R Rogers, Patricia LoRusso, Paul Nadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2013
Predictive value of phase I trials for safety in later trials and final approved dose: analysis of 61 approved cancer drugs
Denis L Jardim, Kenneth R Hess, Patricia Lorusso, et al.
Scientific Reports
|
August 4, 2019
Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry
Xun Bao, Jianmei Wu, Brian Shuch, et al.
Investigational New Drugs
|
May 10, 2006
A phase I study of flavopiridol and docetaxel
Basil F El-Rayes, Shirish Gadgeel, Ralph Parchment, et al.
Clinical Lung Cancer
|
July 6, 2011
Analysis of lung cancer patients enrolled in CTEP (cancer therapy evaluation program)-sponsored phase I trials
Shirish M Gadgeel, Percy Ivy, Wei Chen, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 3, 2024
Unlocking the Potential: Biomarkers of Response to Antibody-Drug Conjugates
Liliana Ascione, Lorenzo Guidi, Ajay Prakash, et al.
Cancer Chemotherapy and Pharmacology
|
November 19, 2013
Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors
Yi-Lin Chiu, Patricia Lorusso, Balakrishna Hosmane, et al.
Journal of the National Cancer Institute
|
November 22, 2012
Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials
Sachin Gupta, Sally Hunsberger, Scott A Boerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
Phase I study of bryostatin 1 and gemcitabine
Basil F El-Rayes, Shirish Gadgeel, Anthony F Shields, et al.
American Journal of Clinical Oncology
|
April 7, 2007
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin
Basil F El-Rayes, Mark Zalupski, Anthony F Shields, et al.
Page
of 17
Search research articles
Search
Showing results (21-30 of 164) with videos related to
Sort By:
Page
of 17
Journal of Neuro-Oncology
|
June 5, 2010
Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report
Lisa R Rogers, Patricia LoRusso, Paul Nadler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2013
Predictive value of phase I trials for safety in later trials and final approved dose: analysis of 61 approved cancer drugs
Denis L Jardim, Kenneth R Hess, Patricia Lorusso, et al.
Scientific Reports
|
August 4, 2019
Quantitative Profiling of Oncometabolites in Frozen and Formalin-Fixed Paraffin-Embedded Tissue Specimens by Liquid Chromatography Coupled with Tandem Mass Spectrometry
Xun Bao, Jianmei Wu, Brian Shuch, et al.
Investigational New Drugs
|
May 10, 2006
A phase I study of flavopiridol and docetaxel
Basil F El-Rayes, Shirish Gadgeel, Ralph Parchment, et al.
Clinical Lung Cancer
|
July 6, 2011
Analysis of lung cancer patients enrolled in CTEP (cancer therapy evaluation program)-sponsored phase I trials
Shirish M Gadgeel, Percy Ivy, Wei Chen, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
June 3, 2024
Unlocking the Potential: Biomarkers of Response to Antibody-Drug Conjugates
Liliana Ascione, Lorenzo Guidi, Ajay Prakash, et al.
Cancer Chemotherapy and Pharmacology
|
November 19, 2013
Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors
Yi-Lin Chiu, Patricia Lorusso, Balakrishna Hosmane, et al.
Journal of the National Cancer Institute
|
November 22, 2012
Meta-analysis of the relationship between dose and benefit in phase I targeted agent trials
Sachin Gupta, Sally Hunsberger, Scott A Boerner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
Phase I study of bryostatin 1 and gemcitabine
Basil F El-Rayes, Shirish Gadgeel, Anthony F Shields, et al.
American Journal of Clinical Oncology
|
April 7, 2007
A phase I study of gemcitabine and uracil-ftorfar (UFT)/leucovorin
Basil F El-Rayes, Mark Zalupski, Anthony F Shields, et al.
Page
of 17